Abstract
Describe the cardiovascular adverse events associated with TKI therapy for cancer. Develop strategies to minimize or mitigate CV adverse events during TKI treatment.
Cite
CITATION STYLE
APA
Lenihan, D. J., & Kowey, P. R. (2013). Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors. The Oncologist, 18(8), 900–908. https://doi.org/10.1634/theoncologist.2012-0466
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free